Camado, Welma .

HRN: 19-21-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/21/2025
CEFUROXIME 500MG (TAB)
12/21/2025
12/28/2025
ORAL
500mg
BID
Thickly MSAF
Checking Initial Appropriateness 
12/21/2025
METRONIDAZOLE 500MG (TAB)
12/21/2025
12/28/2025
ORAL
500mg
TID
Thickly MSAF
Checking Initial Appropriateness 
12/22/2025
CEFUROXIME 500MG (TAB)
12/22/2025
12/28/2025
PO
500mg
BID
THICKLY MSAF
Waiting Final Action 
12/22/2025
METRONIDAZOLE 500MG (TAB)
12/22/2025
12/28/2025
PO
500mg
TID
THICKLY MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: